Back
Results - Announcements
Sales reported at Rs -0.13 crore
Lasa Supergenerics reports standalone net loss of Rs 4.16 crore in the March 2026 quarter
01-Jun-2026, 07:26
Net Loss of Lasa Supergenerics reported to Rs 4.16 crore in the quarter ended March 2026 as against net loss of Rs 14.29 crore during the previous quarter ended March 2025. Sales reported to Rs -0.13 crore in the quarter ended March 2026 as against Rs 39.14 crore during the previous quarter ended March 2025.
Net Loss of Lasa Supergenerics reported to Rs 4.16 crore in the quarter ended March 2026 as against net loss of Rs 14.29 crore during the previous quarter ended March 2025. Sales reported to Rs -0.13 crore in the quarter ended March 2026 as against Rs 39.14 crore during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 34.09 crore in the year ended March 2026 as against net loss of Rs 14.76 crore during the previous year ended March 2025. Sales declined 82.35% to Rs 25.14 crore in the year ended March 2026 as against Rs 142.45 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | -0.13 | 39.14 | PL | 25.14 | 142.45 | -82 |
| OPM % | 1623.08 | 8.71 | - | -29.28 | 4.39 | - |
| PBDT | -2.20 | 5.69 | PL | -7.55 | 8.58 | PL |
| PBT | -3.51 | 1.79 | PL | -13.57 | -3.72 | -265 |
| NP | -4.16 | -14.29 | 71 | -34.09 | -14.76 | -131 |
Powered by Capital Market - Live News